Erica L. Mayer - Dana-Farber Cancer Institute, Harvard Medical School

基本信息

浏览量：108

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 313 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

DirectHRD Enables Sensitive Scar-Based Classification of Homologous Recombination Deficiency (HRD)

Ruolin Liu, Eugenia Roberts,Heather A Parsons,Elizabeth H Stover,Atish D Choudhury,Justin Rhoades,Timothy Blewett, David D Yang,Joyce F Liu,Erica L Mayer,Viktor A Adalsteinsson

Nucleic acids researchno. 8 (2025)

引用0浏览0WOS引用

First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer

François-Clément Bidard,Erica L Mayer,Yeon Hee Park,Wolfgang Janni,Cynthia Ma,Massimo Cristofanilli,Giampaolo Bianchini,Kevin Kalinsky,Hiroji Iwata,Stephen Chia,Peter A Fasching, Adam Brufsky,Zbigniew Nowecki,Javier Pascual, Lionel Moreau,Shin-Cheh Chen,Nuri Karadurmus, Einav Nili Gal-Yam,Kyung Hae Jung,Sonia Pernas, Sasha McClain, Wei He, Teresa Klinowska,Cynthia Huang-Bartlett, Nicholas C Turner, SERENA-6 Study Group

The New England journal of medicine (2025)

引用0浏览0WOS引用

Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors

Philip D Tracy, Emily Bopp, Emily Milner,Ana C Garrido-Castro, Antonio Giordano,Erica L Mayer,Sara M Tolaney,Paolo Tarantino,Ilana Schlam

Current oncology reports (2025)

引用0浏览0WOS引用

Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2-early Breast Cancer: a Discrete Choice Survey Study

Erica L. Mayer,Mary Lou Smith,Annie Guérin,Dominick Latremouille-Viau,Nisha C. Hazra, Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy, Liz Santarsiero,Robert Morlock, Maryam B. Lustberg

Breast Cancer Research and Treatmentno. 1 (2025): 121-130

引用0浏览0WOS引用

Impact of Adding Palbociclib on Treatment Adherence to Ongoing Adjuvant Endocrine Treatment in the Global Randomized PALLAS Randomized Trial in Patients with Early Breast Cancer

Eileen Shinn,David Zahrieh,Angela DeMichele, Nick Zdenkowski,Julie Lemieux, Jun Mao,Vesna Bjelic-Radisic, Michelle J. Naughton,Georg Pfeiler, Karen Gelmon,Justin M. Balko,Daniel Egle,Gabriele Zoppoli, Tiffany Traina,Miguel Martin Jimenez, Silvia Antolin Novoa, Tufia Haddad,Arlene Chan,Alistair Ring,Antonio Wolff,William Fraser Symmans, Jose Ponce Lorenzo,Dhanusha Sabanathan, Hal J. Burstein,Zbigniew Ireneusz Nowecki, Gunda Pristauz-Telsnigg,Adam Brufsky, Meritxell Bellet-Ezquerra,Theodoros Foukakis,Yelena Novik,Gabor Rubovszky,Christian F. Singer,Karoline Muehlbacher, Otto Metzger Filho,Theodora Goulioti, Ernest Law,Ann H. Partridge,Lisa A. Carey,Alex Zoroufy,Dominik Hlauschek,Christian Fesl,Erica L. Mayer,Michael Gnant

Breast Cancer Research and Treatmentpp.1-13, (2025)

引用0浏览0WOS引用

Incidence of Patient-Reported Fatigue Developing on Palbociclib and Endocrine Therapy for Advanced HR+ HER2- Breast Cancer

Shadab A. Rahman,Hanneke Poort,Deborah Schrag,Stephanie C. Tung,Eric S. Zhou,Aleta Wiley,Lauren B. Finkelstein,Elkhansaa Elguenaoui, Moira Nolan,Erica L. Mayer,Hadine Joffe

ONCOLOGIST（2024）

引用1浏览0WOS引用

Supplementary Figure S1 from A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer

Antonio Giordano,Priya U. Kumthekar,Qingchun Jin,Busem Binboga Kurt,Siyang Ren,Tianyu Li,Jose Pablo Leone,Elizabeth A. Mittendorf,Alyssa M. Pereslete,Laura Sharp,Raechel Davis,Molly DiLullo,Nabihah Tayob,Erica L. Mayer,Eric P. Winer,Sara M. Tolaney,Nancy U. Lin

crossref（2024）

引用0浏览0引用

Is Preventative Oophorectomy Safe

Megan E. Tesch, Douglas E. Drachman,Erica L. Mayer

JACC CardioOncologyno. 6 (2024): 932-934

引用0浏览0引用

Supplementary Table S6 from A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn